secwatch.observer — SEC 8-K summary
======================================

Issuer:     REVELATION BIOSCIENCES, INC. (REVB)
CIK:        0001810560
Form:       8-K
Filed at:   2026-01-29T23:59:59+00:00
Accession:  0001193125-26-027742
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 3.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Revelation Biosciences raises ~$7.3M via warrant exercise; issues new warrants
------------------------------------------------------------------------------

- Two holders exercised 8,544,999 pre-split Class I warrants at $0.86/share, gross proceeds ~$7.3M.
- Company issued 17,089,998 pre-split new Class J warrants at $0.86/share, exercisable only after stockholder approval.
- Net proceeds to fund clinical development and working capital.
- Third investor withdrew; filing corrects earlier press release that had included them.
- Roth Capital Partners received 8% cash fee of gross proceeds as financial advisor.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1810560/000119312526027742/0001193125-26-027742-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1810560/000119312526027742/revb-20260126.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-027742

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer